Virtual Roundtables for IP Leaders within Life Sciences


IP Collective for Life Sciences

Wednesday, June 10, 2026

11:00 AM - 4:00 PM ET

Virtual | US and Canada Only

Exclusively for senior-level executives

Our events are invitation-only and limited to senior level executives. This ensures every conversation happens at the right level - between people with the experience, context, and authority to speak openly and challenge ideas.

Discussions, not presentations

Our roundtables are discussion-based, ensuring everyone in the room is actively involved. Some leaders arrive seeking answers on specific challenges; others come to share experience and insight. The result is focused, peer-level conversations around real challenges - without sales pitches or passive listening.

Led by peers

Each roundtable is facilitated by an experienced industry leader who guides the conversation, keeps discussion focused, and ensures every participant has the opportunity to contribute.

Discussions are driven by shared experience - where insight is exchanged openly and trust builds naturally.

Testimonials

  • "Informative and enjoyable. I was pleasantly surprised by the diversity of ideas and backgrounds of the participants, which made for stimulating conversations."

    — Senior Director, Assistant General Counsel, Dispute Resolution, Regeneron

  • "I had a great time learning about the experiences of other IP professionals with implementing AI tools and portfolio management. It was interesting hearing the differences in organizational approaches in the therapeutic market versus the diagnostic market."

    — Associate General Counsel, IDEXX

  • "Had a very positive experience with colleagues across different locations at these Roundtables. The moderators were well prepared and facilitated the conversation effectively, sharing their own experiences. The atmosphere was not tense. Instead, an open and free discussion was encouraged."

    — Senior Legal Counsel, ERGOMED

  • "It was great to speak to colleagues working in the IP field and coming from very different backgrounds (from start-ups to large multinational companies) and exchange their experiences. The discussions have given me ideas on how to improve the interactions with internal and external stakeholders."

    — Patent Counsel, Dipharma